The effects of dexmedetomidine on postoperative tumor recurrence and patient survival after breast cancer surgery: a feasibility study
Abstract Purpose Dexmedetomidine (Dexmed) is a highly selective alpha 2 adrenoceptor (α2-AR) agonist with excellent sedation and analgesic effects and is frequently used in breast cancer surgery. However, the exact impact of Dexmed on breast cancer prognosis is still unclear. The primary objective o...
Main Authors: | Jiamei Luo, Wei Xuan, Jiaxin Sun, Xiaoqiang Wang, Yumiao Shi, Yiqi Zhang, Wenjin Yin, Huigang Shu, Jinsong Lu, Jie Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-11-01
|
Series: | Anesthesiology and Perioperative Science |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44254-023-00037-z |
Similar Items
-
Effect of intraoperative use of low-dose dexmedetomidine on the prognosis of patients undergoing breast cancer surgery
by: YANG Xiaoxuan, et al.
Published: (2023-02-01) -
Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study
by: Mansour Bahardoust, et al.
Published: (2023-10-01) -
Management of Recurrent Meningiomas: State of the Art and Perspectives
by: Marco Vincenzo Corniola, et al.
Published: (2022-08-01) -
Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
by: Lidi Ma, et al.
Published: (2022-02-01) -
Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching
by: Zhaoqin Wu, et al.
Published: (2022-03-01)